• Palonosetron Hydrochloride in CINV: Innovation and Clinical

  2026-06-20

  Ruhlmann and Herrstedt’s review provides a detailed examination of palonosetron hydrochloride, highlighting its unique pharmacological properties and clinical advantages in preventing chemotherapy-induced nausea and vomiting (CINV). The article synthesizes preclinical and clinical evidence, emphasizing palonosetron’s superiority in delayed-phase emesis control and its implications for antiemetic regimen design.

• Methicillin Sodium Salt: Optimizing MSSA Research Workflows

  2026-06-19

  Methicillin sodium salt enables precise, reproducible modeling of methicillin-sensitive Staphylococcus aureus (MSSA) infections, thanks to its well-characterized mechanism as a bacterial cell wall synthesis inhibitor. This article delivers stepwise protocols, troubleshooting strategies, and advanced research insights that leverage APExBIO’s high-purity Methicillin sodium salt for robust experimental outcomes.

• ML133 HCl: A Selective Potassium Channel Inhibitor for Kir2.

  2026-06-19

  ML133 HCl delivers unmatched selectivity for Kir2.1 potassium channels, empowering researchers to dissect pulmonary artery smooth muscle cell proliferation with precision. Its robust performance in both in vitro and in vivo models sets a new standard in cardiovascular ion channel research.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Workflow, Tips, and

  2026-06-18

  The Cy5 Goat Anti-Mouse IgG (H+L) Antibody offers robust signal amplification and high specificity for immunohistochemistry, immunocytochemistry, and flow cytometry using mouse antibodies. This guide translates research findings into actionable workflows, advanced assay applications, and troubleshooting tips for achieving high-sensitivity fluorescent detection.

• pH-Responsive cRGD-PEG-siRNA: Targeted Glioblastoma Therapy

  2026-06-18

  This study introduces a cRGD-PEG-siEGFR conjugate engineered for pH-sensitive, highly targeted siRNA delivery to glioblastoma cells. The compound demonstrates improved tumor selectivity, reduced renal toxicity, and enhanced antitumor efficacy, marking an important advance in gene-based therapies for malignant brain tumors.

• 5-Azacytidine: Dormancy Reprogramming and Metastasis Suppres

  2026-06-17

  Explore how 5-Azacytidine enables next-generation cancer models by reprogramming disseminated cancer cells into dormancy and suppressing metastasis. This article examines 5-AzaC's unique mechanism, differentiating it from standard demethylation workflows.

• Bsa I (RNase-free): Technical Parameters for DNA Manipulatio

  2026-06-17

  Bsa I (RNase-free) enables precise DNA cleavage in workflows where RNA integrity is critical, such as gene cloning and DNA recombinant technology. It should only be used in research protocols requiring RNase-free conditions and is unsuitable for diagnostic or clinical applications.

• BX795 PDK1 Inhibitor: Advanced Workflows for Immunity & Canc

  2026-06-16

  BX795 is a potent, ATP-competitive PDK1 inhibitor that empowers researchers to dissect PI3K/Akt/mTOR and innate immune pathways with precision. This article details practical workflows, troubleshooting strategies, and cross-domain applications, leveraging recent mechanistic insights and data-driven protocol enhancements.

• HyperScribe™ T7 Cy5 RNA Labeling Kit: Illuminating RNA–Prote

  2026-06-16

  Explore how the HyperScribe T7 High Yield Cy5 RNA Labeling Kit empowers advanced viral RNA–protein interaction studies and probe design. This article offers unique insights into optimizing fluorescent nucleotide incorporation for applications beyond current benchmarks.

• IL-1β-NF-κB Drives ACE2 Upregulation and Macrophage Infectio

  2026-06-15

  Lee et al. establish a novel humanized ACE2 mouse model to dissect how IL-1β-driven NF-κB activation increases ACE2 expression in macrophages, enabling productive SARS-CoV-2 infection. Their findings illuminate dynamic immune regulation of viral entry and provide a robust platform for future studies on host susceptibility and antiviral responses.

• U-73122: Phospholipase C Inhibitor for Advanced Signal Modul

  2026-06-15

  U-73122, a selective phospholipase C inhibitor, empowers researchers to dissect calcium signaling and chemotactic responses with precision. This guide translates bench-proven workflows and troubleshooting strategies into actionable insights for inflammation, oncology, and migration assays.

• ABT-263 (Navitoclax): Optimizing Apoptosis Assays in Cancer

  2026-06-14

  ABT-263 (Navitoclax) enables robust, high-sensitivity apoptosis assays and targeted cancer biology workflows. Integrating recent PDX research, it offers practical advantages for overcoming chemoresistance and tailoring protocols to complex tumor models.

• AAPH-Induced Protein Oxidation: Precision Tools for Food and

  2026-06-13

  Discover how AAPH (2,2'-Azobis(2-methylpropionamidine) dihydrochloride) uniquely enables controlled oxidative stress modeling, with scientific insights bridging food protein research and biomedical assay design.

• Optimizing Cell Assays with EMD638683 (SGK1 Inhibitor): Best

  2026-06-12

  This article provides scenario-driven guidance for biomedical researchers seeking reproducibility and mechanistic clarity in cell viability, proliferation, and cytotoxicity assays using EMD638683 (SGK1 inhibitor, SKU A3389). Drawing on recent literature and validated workflows, it addresses practical hurdles—from kinase selectivity to vendor reliability—grounding each recommendation in quantitative data and protocol specifics.

• Nr4a1–C3 Axis Drives TMJ Inflammation-Linked Synaptic Prunin

  2026-06-12

  This study identifies microglial Nr4a1 deficiency and neuronal C3 deposition as key mediators of hippocampal synaptic loss and depression-like behaviors following TMJ inflammation. The findings highlight novel molecular targets for understanding and potentially treating neuroimmune complications in temporomandibular disorders.

421 records 12/29 page Previous Next First page 上5页 1112131415 下5页 Last page